MTMotohide Takemura

Motohide Takemura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Motohide Takemura has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Shinichi Sugiyo

    Department of Oral Anatomy and Neurobiology, Osaka University Graduate School of Dentistry

    3 shared publications
  • T. Shimada

    Department of Oral Anatomy, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan

    3 shared publications
  • Y. Shigenaga

    Department of Oral Anatomy, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan

    3 shared publications
  • Yoshio Shigenaga

    Department of Oral Anatomy and Neurobiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan

    3 shared publications
  • A Yoshida

    2 shared publications
  • M Moritani

    2 shared publications

Latest Publications

  • Effects of systemic bicuculline or morphine on formalin-evoked pain-related behaviour and c-Fos expression in trigeminal nuclei after formalin injection into the lip or tongue in rats

    by S. Sugiyo, D. Uehashi, F. Satoh, T. Abe, N. Yonehara, M. Kobayashi, Motohide Takemura

    This study examined differences in nociceptive responses between lip and tongue. Formalin-induced pain-related behaviour and c-Fos expression in the trigeminal caudal nucleus (Vc) with/without systemic preadministration of a γ-aminobutyric acid (GABA) type A receptor antagonist, bicuculline (2 mg/kg, i.p., 10 min before formalin injection) or a μ-opioid receptor agonist, morphine (3 mg/kg, i.p., 10 min before formalin injection) have been studied. Formalin injection into the upper lip induced an immediate pain-related behaviour, mostly face-rubbing behaviour, for 15 min (phase 1, mean ± SEM/5 min, 81.2 ± 30.1), followed by a more increased activity for 15 min (phase 2, 205.4 ± 43.6) and a decline to baseline for next 15 min (phase 3, 63.9 ± 28.0). Formalin injection into the tongue induced similar amount of pain-related behaviour at phase 1 (67.9 ± 16.7), followed by similar activity at phase 2 (48.6 ± 6.2), and lesser behaviour at phase 3 (20.4 ± 7.6). The behaviour at phase 2 decreased following preadministration of bicuculline or morphine when formalin was injected into the lip (b, 62.5 ± 14.5; m, 95.8 ± 10.0) but not into the tongue (b, 31.0 ± 9.2; m, 77.4 ± 27.0). A considerable numbers of c-Fos-immunoreactive (IR) cells were induced in the caudal and inter-medio-lateral center of superficial layers of the Vc (VcI/II; mean ± SEM/section = 225.8 ± 12.9) and magnocellular zone of the Vc (VcIII/IV; 67.1 ± 4.7) 2 h after formalin injection into the lip. Much smaller numbers of c-Fos-IR cells were induced in the rostral and dorso-medial one-fourth of the VcI/II (72.6 ± 3.7) and VcIII/IV (55.6 ± 6.6) after formalin injection into the tongue. Following preadministration with systemic bicuculline or morphine, the formalin-induced c-Fos-IR cells were decreased more in the VcI/II when formalin was injected into the lip (VcI/II, 102.4 ± 8.0; VcIII/IV, 32.8 ± 1.4) than into the tongue (VcI/II, 49.5 ± 8.1; VcIII/IV, 31.7 ± 5.3). These results show that the lip is more sensitive to formalin-induced noxious stimulation and regulated more through GABAA and μ-opioid receptors than the tongue.


  • Open Access

    Mechanisms of orofacial pain control in the central nervous system

    by Motohide Takemura, Shinichi Sugiyo, Masayuki Moritani, Masayuki Kobayashi, Norifumi Yonehara

    Recent advances in the study of pain have revealed somatotopic- and modality-dependent processing and the integration of nociceptive signals in the brain and spinal cord. This review summarizes the uniqueness of the trigeminal sensory nucleus (TSN) in structure and function as it relates to orofacial pain control. The oral nociceptive signal is primarily processed in the rostral TSN above the obex, the nucleus principalis (Vp), and the subnuclei oralis (SpVo) and interpolaris (SpVi), while secondarily processed in the subnucleus caudalis (SpVc). In contrast, the facial nociceptive signal is primarily processed in the SpVc. The neurons projecting to the thalamus are localized mostly in the Vp, moderately in the SpVi, and modestly in the ventrolateral SpVo and the SpVc. Orofacial sensory inputs are modulated in many different ways: by interneurons in the TSN proper, through reciprocal connection between the TSN and rostral ventromedial medulla, and by the cerebral cortex. A wide variety of neuroactive substances, including substance P, γ-aminobutyric acid, serotonin and nitric oxide (NO) could be involved in the modulatory functions of these curcuits. The earliest expression of NO synthase (NOS) in the developing rat brain is observed in a discrete neuronal population in the SpVo at embryonic day 15. NOS expression in the SpVc is late at postnatal day 10. The neurons receiving intraoral signals are intimately related with the sensorimotor reflexive function through the SpVo. In summary, a better understanding of the trigeminal sensory system - which differs from the spinal system - will help to find potential therapeutic targets and lend to developing new analgesics for orofacial-specific pain with high efficacy and fewer side effects.


  • Characteristics of the trigeminal depressor response in cats

    by Naohiro Ohshita, Nobuyoshi Nakajo, Motohide Takemura

    We studied the effects of electrical stimulation of the inferior alveolar nerve (IAN) on cardiovascular responses in cats. There was statistical correlation between cardiovascular response and prestimulus mean arterial blood pressure (MABP) and heart rate (HR). A trigeminal depressor response (TDR) was induced when the prestimulus MABP and HR were above 95 mm Hg and 140 beats/min, respectively. We investigated further to identify the vasomotor regulating center and neural transmitters involved in TDR. In the medulla, electrical stimulation of the dorsomedial medulla, the infratrigeminal nucleus (IFT), and the rostral ventrolateral medulla (RVLM) induced a vasopressor response. We confirmed that neurons in the RVLM were retrogradely labeled by wheat germ agglutinin‐conjugated horseradish peroxidase injection into the nucleus intermediolateralis of the spinal cord. The vasopressor response induced by IFT stimulation was similar to that induced by IAN stimulation. Vasodepressor responses were induced when the caudal ventrolateral medulla, the nucleus tractus solitarius, the lateral tegmental field, the trigeminal nucleus interpolaris, the trigeminal spinal tract, and the paramedian reticular nucleus were stimulated. These responses, however, were not similar to the vasodepressor response induced by IAN stimulation but were similar to the cardiovascular response induced by vagal afferent stimulation. After spinalization or lesion of the RVLM, MABP and HR decreased and TDR completely disappeared. Inhibitory synaptic ligands and receptors were localized using immunohistochemical techniques. Neurons immunopositive for adrenaline, noradrenaline, and γ‐aminobutyric acid (GABA), and adrenaline α2A, GABAA, GABAB, and glycine receptors were distributed along the sympatho‐reflexive route including the RVLM and IFT. These results suggest that TDR could be induced as negative feedback to sympathetic hyperactivity whenever MABP and HR are high, because of the inhibitory control of the RVLM.


  • Effects of somatosensory cortical stimulation on expression of c‐Fos in rat medullary dorsal horn in response to formalin‐induced noxious stimulation

    by Fusami Gojyo, Shinichi Sugiyo, Ryotaro Kuroda, Atsufumi Kawabata, Vidya Varathan, Yoshio Shigenaga, Motohide Takemura

    We examined the effects of epidural electrical stimulation of primary (SI) and secondary (SII) somatosensory cortex on expression of c‐Fos protein in rat medullary dorsal horn neurons (Vc; trigeminal nucleus caudalis) in response to formalin‐induced noxious stimulation. Epidural electrical stimulation (single pulse, 0.2 msec duration at 10 Hz) was applied to the left facial region SI or SII at three different stimulus intensities, 0.1, 0.5, and 1.0 mA for 60 min 0 or 2 hr after bilateral injection of formalin into the lower lip. SII stimulation at 1.0 mA immediately after injection of formalin, significantly decreased the number of Fos‐positive cells in the right VcI/II by 32.4%. There was no significant change in the number of Fos‐positive cells in the VcIII/IV. SII stimulation at 0.5 and 1.0 mA 2 hr after injection of formalin, significantly decreased the number of Fos‐positive cells in the right VcI/II by 47.9% and 40.8%, but significantly increased the number of Fos‐positive cells in the right VcIII/IV by 178.8% and 324.3%, respectively. In contrast, SI stimulation had no effect on expression of c‐Fos in Vc. Possible direct corticotrigeminal projections were labeled anterogradely by injection of WGA‐HRP into the SI and SII. In the Vc, labeled terminals were distributed mostly in the contralateral medial half of VcIII/IV and medullary reticular nucleus dorsalis but rarely in VcI/II. These results suggest that activation of SII‐medullary fibers suppress nociceptive information from the oro‐facial regions.


  • Effects of intrathecal c-fos antisense oligodeoxynucleotide on adjuvant-induced thermal hyperalgesia

    by Shinichi Sugiyo, Norifumi Yonehara, Kwabena Appenteng, Takashi Nokubi, Yoshio Shigenaga, Motohide Takemura

    We examined the effects of intrathecally preadministered injections of a phosphorothioate analog of c-fos antisense and mismatch oligodeoxynucleotides (ODNs) on the withdrawal latency to a thermal stimulus following unilateral injection of complete Freund's adjuvant (CFA) into the hind footpad of rats. Pretreatment with the c-fos antisense ODN significantly decreased the CFA-induced expression of c-Fos protein dose-dependently in ipsilateral laminae I/II (LI/II) of the dorsal horn (mean ± SEM per section: 10 nM ODN, 43.9±1.3; 25 nM ODN, 19.4±4.1) compared with pretreatment with the mismatch ODN (63.6±2.9; 60.6±4.0) or saline (56.6±5.5). Animals pre-treated with 25 nM of the c-fos antisense ODN significantly increased the withdrawal latency to the noxious thermal stimulation (63.0–70.5%; compared with contralateral to the CFA injection) compared with animals pretreated with mismatch ODN (28.5–42.6%) or saline (26.4–45.3%) from 0 to 5 h after unilateral injection of CFA into the hind footpad. Pretreatment with 10 nM antisense ODN had a less significant effect. These results indicate that the expression of CFA-induced c-Fos in the dorsal horn might facilitate thermal nociception.


  • Ontogeny of NADPH-diaphorase in rat forebrain and midbrain

    by K. Iwase, M. Takemura, T. Shimada, S. Wakisaka, T. Nokubi, Y. Shigenaga

    This study characterizes the developmental expression of NADPH-diaphorase from embryo to adulthood in the forebrain, midbrain and cerebellum of rat brain via histochemical staining. On embryonic day 12 no neurons stained. Labeling was observed in certain nuclei from E15 through the postnatal period to adulthood. Labeling in neurons increased or maintained a constant level with increased age. The embryo demonstrated substantial labeling in neurons of the caudate putamen, bed nucleus of the stria terminalis, preoptic area, lateral hypothalamic area, paraventricular thalamic nucleus, ventromedial hypothalamic nucleus, magnocellular nucleus posterior commissure, and periaqueductal central gray. Additional neuronal labeling was observed postnatally in the olfactory bulb, cerebral cortex, amygdala, various nuclei of the thalamus, interpeduncular nucleus, linear nucleus of the raphe, pretectal area and superior colliculus. In the cerebellum, labeling appeared only after P14 in cells of the molecular cell layer and granular cell layer. The sizes of labeled neurons developed significantly from P4 to P14 in several nuclei. The distinctive temporal and spatial expression pattern of NADPH-diaphorase implies that the NO/cGMP system may play an important role in physiological and developmental functions.